Association Between Use of β-Blockers and Outcomes in Patients With Heart Failure and Preserved Ejection Fraction-Reference-Cited by-同舟云学术

Association Between Use of β-Blockers and Outcomes in Patients With Heart Failure and Preserved Ejection Fraction

Published:2014-11-19 Issue:19 Volume:312 Page:2008
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Lund Lars H.¹,Benson Lina²,Dahlström Ulf³,Edner Magnus⁴,Friberg Leif⁵

Affiliation:

1. Unit of Cardiology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden2Department of Cardiology, Karolinska University Hospital, Stockholm, Sweden

2. Department of Clinical Science and Education, Karolinska Institutet, South Hospital, Stockholm, Sweden

3. Department of Cardiology and Department of Medical and Health Sciences, Linköping University, Linköping, Sweden

4. Unit of Cardiology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden

5. Department of Clinical Sciences, Karolinska Institutet, Danderyd Hospital, Stockholm, Sweden6Department of Cardiology, Danderyd Hospital, Stockholm, Sweden

Publisher

American Medical Association (AMA)

Subject

General Medicine

Cited by 144 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Heart failure with preserved ejection fraction epidemiology, pathophysiology, diagnosis and treatment strategies;International Journal of Cardiology;2024-10

2. Guía latinoamericana de recomendaciones al egreso de un síndrome coronario agudo;Archivos de Cardiología de México;2024-06-05

3. Comparison of clinical characteristics and prognostic factors in patients with heart failure with preserved ejection fraction with and without renal dysfunction;Minerva Cardiology and Angiology;2024-05

4. (Focused on heart failure treatment according to the updated 2023 guidelines);Cor et Vasa;2024-04-26

5. Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment;Clinical Research in Cardiology;2024-04-11